微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 52.15% | -7.04% | -6.86% | 5/52 | 36.42% | 诺泰生物 | 69.32% | 行业排名> |
| 2024-06-30 | 55.99% | -1.65% | -6.03% | 5/52 | 36.51% | 百诚医药 | 68.75% | 行业排名> |
| 2024-03-31 | 59.58% | 20.88% | 5.11% | 5/52 | 36.38% | 百诚医药 | 68.19% | 行业排名> |
| 2023-12-31 | 56.68% | 2.15% | 1.05% | 4/52 | 38.59% | 药康生物 | 67.61% | 行业排名> |
| 2023-09-30 | 56.09% | -1.44% | -1.46% | 5/52 | 40.29% | 药康生物 | 69.14% | 行业排名> |
| 2023-06-30 | 56.93% | -2.47% | 15.5% | 5/52 | 40.13% | 药康生物 | 68.49% | 行业排名> |
| 2023-03-31 | 49.29% | -12.91% | -11.18% | 8/52 | 39.27% | 药康生物 | 69.3% | 行业排名> |
| 2022-12-31 | 55.49% | 3.89% | -2.5% | 5/52 | 40.44% | 药康生物 | 71.38% | 行业排名> |
| 2022-09-30 | 56.91% | 0.87% | -2.49% | 4/52 | 41.37% | 药康生物 | 73.27% | 行业排名> |
| 2022-06-30 | 58.37% | 4.88% | 3.13% | 3/52 | 40.21% | 药康生物 | 75.32% | 行业排名> |
| 2022-03-31 | 56.59% | 3.81% | 5.95% | 5/52 | 38.93% | 药康生物 | 76.7% | 行业排名> |
| 2021-12-31 | 53.41% | 7.66% | -5.33% | 9/52 | 42.21% | 药康生物 | 74.33% | 行业排名> |
| 2021-09-30 | 56.42% | 12.13% | 1.38% | 7/52 | 43.4% | 南华生物 | 84.53% | 行业排名> |
| 2021-06-30 | 55.65% | 2% | 2.08% | 8/52 | 42.88% | 南华生物 | 83.19% | 行业排名> |
| 2021-03-31 | 54.52% | 20.21% | 9.89% | 4/52 | 40.06% | 南华生物 | 83.9% | 行业排名> |
| 2020-12-31 | 49.61% | 8.11% | -1.4% | 18/52 | 38.9% | 成都先导 | 79.36% | 行业排名> |
| 2020-09-30 | 50.32% | 2% | 10.94% | 5/52 | 37.76% | 成都先导 | 75.92% | 行业排名> |
| 2020-03-31 | 45.35% | 2% | -1.17% | 12/52 | 33.2% | 南华生物 | 78.74% | 行业排名> |
| 2019-12-31 | 45.89% | 8.27% | 8.27% | 18/52 | 43.15% | 成都先导 | 80.82% | 行业排名> |
| 2018-12-31 | 42.39% | 6.71% | 6.71% | 25/52 | 42.47% | 成都先导 | 81.55% | 行业排名> |
| 2017-12-31 | 39.72% | 2% | 2% | 26/52 | 41.42% | 海特生物 | 84.37% | 行业排名> |